These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study. Tekin K, Sekeroglu MA, Cankaya AB, Teke MY, Doguizi S, Yilmazbas P. Semin Ophthalmol; 2018; 33(2):265-270. PubMed ID: 27841949 [Abstract] [Full Text] [Related]
51. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study. Bae S, Jin K, Kim H, Bae SH. BMC Ophthalmol; 2015 Dec 18; 15():180. PubMed ID: 26677843 [Abstract] [Full Text] [Related]
52. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Int Ophthalmol; 2017 Jun 18; 37(3):483-489. PubMed ID: 27392913 [Abstract] [Full Text] [Related]
57. Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy. Shulman S, Goldenberg D, Schwartz R, Habot-Wilner Z, Barak A, Ehrlich N, Loewenstein A, Goldstein M. Graefes Arch Clin Exp Ophthalmol; 2016 Jan 18; 254(1):15-22. PubMed ID: 25794988 [Abstract] [Full Text] [Related]
58. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Baek J, Lee JH, Jung BJ, Kook L, Lee WK. Graefes Arch Clin Exp Ophthalmol; 2018 Dec 18; 256(12):2309-2317. PubMed ID: 30259090 [Abstract] [Full Text] [Related]
59. Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. Mattingly JJ, Amram AL, El-Annan J. Can J Ophthalmol; 2018 Oct 18; 53(5):e182-e183. PubMed ID: 30340736 [No Abstract] [Full Text] [Related]
60. Blood flow velocity and thickness of the choroid in a patient with chorioretinopathy associated with ocular blunt trauma. Ishikawa Y, Hashimoto Y, Saito W, Ando R, Ishida S. BMC Ophthalmol; 2017 Jun 08; 17(1):86. PubMed ID: 28595625 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]